Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Consolidated Midland Corporation was a pharmaceutical company based in Brewster, New York, that specialized in the manufacture and distribution of generic prescription drugs and over-the-counter (OTC) healthcare products. Established in the mid-20th century, the company built a reputation for providing a broad range of legacy small molecule medications to the U.S. market. Its product portfolio spanned various therapeutic areas, including pain management, respiratory health, and general medicine. In 2005, the company was acquired by The Harvard Drug Group, a major distributor of generic pharmaceuticals. Following the acquisition, Consolidated Midland's operations were integrated into the parent organization. The Harvard Drug Group was subsequently acquired by Cardinal Health in 2015, effectively making Consolidated Midland's legacy assets part of one of the largest healthcare services companies in the world.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Consolidated Midland.